Olivieri, Anamaria-Vera http://orcid.org/0000-0002-0947-3002
Muratov, Sergey
Larsen, Sara
Luckevich, Maria http://orcid.org/0000-0002-4308-2574
Chan, Katalina
Lamotte, Mark
Lau, David C. W. http://orcid.org/0000-0002-1780-9039
Article History
Received: 5 October 2022
Revised: 9 January 2024
Accepted: 11 January 2024
First Online: 31 January 2024
Competing interests
: IQVIA, the employer of AVO, SM, and MLa (at the moment of the project development) received consulting fees from Novo Nordisk for the development of the model and conducting the analyses reported in this manuscript. SL, MLu, and KC are full-time employees of Novo Nordisk. DCWL received consulting fees from Amgen, Bayer, Boehringer Ingelheim, HLS Therapeutics, Eli Lilly, Novartis, Novo Nordisk, Pfizer, and Viatris.